- Home
- MCVT vs PSTV Comparison
MCVT vs PSTV Comparison
Compare MCVT & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCVT
- PSTV
- Stock Information
- Founded
- MCVT 2007
- PSTV 1996
- Country
- MCVT United States
- PSTV United States
- Employees
- MCVT N/A
- PSTV N/A
- Industry
- MCVT Finance Companies
- PSTV Medical/Dental Instruments
- Sector
- MCVT Finance
- PSTV Health Care
- Exchange
- MCVT Nasdaq
- PSTV Nasdaq
- Market Cap
- MCVT 9.3M
- PSTV 10.4M
- IPO Year
- MCVT N/A
- PSTV N/A
- Fundamental
- Price
- MCVT $1.83
- PSTV $0.36
- Analyst Decision
- MCVT
- PSTV Strong Buy
- Analyst Count
- MCVT 0
- PSTV 3
- Target Price
- MCVT N/A
- PSTV $10.83
- AVG Volume (30 Days)
- MCVT 16.1K
- PSTV 67.2M
- Earning Date
- MCVT 08-13-2025
- PSTV 08-13-2025
- Dividend Yield
- MCVT N/A
- PSTV N/A
- EPS Growth
- MCVT N/A
- PSTV N/A
- EPS
- MCVT 0.19
- PSTV N/A
- Revenue
- MCVT $3,246,479.00
- PSTV $5,206,000.00
- Revenue This Year
- MCVT N/A
- PSTV $13.26
- Revenue Next Year
- MCVT N/A
- PSTV $8.84
- P/E Ratio
- MCVT $9.65
- PSTV N/A
- Revenue Growth
- MCVT N/A
- PSTV N/A
- 52 Week Low
- MCVT $1.13
- PSTV $0.16
- 52 Week High
- MCVT $3.88
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- MCVT 50.24
- PSTV 47.17
- Support Level
- MCVT $1.77
- PSTV $0.17
- Resistance Level
- MCVT $1.91
- PSTV $0.44
- Average True Range (ATR)
- MCVT 0.08
- PSTV 0.05
- MACD
- MCVT -0.01
- PSTV 0.02
- Stochastic Oscillator
- MCVT 36.11
- PSTV 55.39
About MCVT Mill City Ventures III Ltd.
Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that the group provides are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).